{"effective_time":"20241204","id":"61f308f8-a1e8-4061-96b3-b6f92a9a588e","openfda":{},"package_label_principal_display_panel":["PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1436-4 in blister-carton of 4 (1 x 4) Unit-dose Tablets Risedronate Sodium Delayed-release Tablets, 35 mg R x only 4 Tablets Risedronate Sodium DR Tablets, 35 mg Risedronate Sodium DR Tablets, 35 mg Risedronate Sodium DR Tablets, 35 mg"],"set_id":"37c8bed0-8cfe-445d-b506-bd89c8fae1a9","spl_medguide":["","SPL MEDGUIDE"],"spl_product_data_elements":["Risedronate Sodium Risedronate Sodium RISEDRONATE SODIUM ANHYDROUS RISEDRONIC ACID EDETATE DISODIUM FERRIC OXIDE YELLOW MAGNESIUM STEARATE POLYSORBATE 80 METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER CELLULOSE, MICROCRYSTALLINE SODIUM STARCH GLYCOLATE TYPE A POTATO STEARIC ACID TALC TRIETHYL CITRATE YELLOW ROUND 75"],"version":"6"}